VAIM Global Participates in AMWC ASIA...Expanding Its Footprint in Asia

VAIM Global Participates in AMWC ASIA...Expanding Its Footprint in Asia

May 31, 2024 –VAIM Global, a subsidiary of global medical aesthetics company VAIM, is expanding its presence in Asia after launching its products in Taiwan in March.

On May 31, VAIM Global announced that it participated in the Aesthetic Medicine World Congress ASIA (AMWC ASIA), held at the International Conference Center in Taipei, Taiwan, from May 24 to 26 to showcase the excellence of JUVELOOK, an autologous collagen-generating filler product. AMWC ASIA, which marks its 6^th year, is a conference where domestic and international aesthetic professionals and industry stakeholders gather to discuss trends in the aesthetic and anti-aging medicine market. This year's event attracted more than 100 companies from 42 countries and over 2,000 visitors.

During the event, VAIM Global gave a lecture on skin regeneration, which has recently emerged as a trend in the aesthetics market, and was well received by visitors. As the representative speaker, Dr. Hong-seok Kim, Director of VOS Dermatology Clinic, delivered a lecture on research on the unique combination of PDLLA and HA in skin regeneration using JUVELOOK and LENISNA (Korean product name: JUVELOOK Volume), and shared the positive effects of PDLLA, the main ingredient of JUVELOOK, on skin regeneration. In addition, Dr. Yanagawa, a representative of Yanagawa Clinic in Japan, delivered a lecture on How to improve skin quality using small particle size PDLLA and shared his know-how of JUVELOOK treatment based on his rich clinical experience.

In addition, VAIM Global used the exhibition booth to raise awareness of the product and communicate with overseas buyers and medical staff. Visitors to the booth were interested in PDLLA's small particle size, which makes it possible to treat fine areas such as fine wrinkles around the eyes and mouth, and its biodegradable polymer, which leaves no residue in the body and degrades safely.

A representative from VAIM Global said, “despite the event being held in Taiwan, we were able to confirm once again the high demand in the Asian aesthetics market, not only in Asia, but also in Europe and South America.” “With this interest, VAIM Global will continue to strengthen its global competitiveness with products that meet the needs of consumers,” the representative added.

Meanwhile, VAIM Global is planning to further accelerate its overseas marketing activities by launching bus and taxi advertisements in Taiwan from June and participating in AMWC Latin America in October.

Introduction of VAIM
Founded in 2014, VAIM is a global medical aesthetics company that develops human tissue regeneration products and improved pharmaceuticals by utilizing its accumulated technology and know-how in biocompatible and biodegradable polymers. It has developed and patented a PDLLA-based manufacturing technology that reduces the risk of nodule formation compared to other ingredient structures, and in 2019, its subsidiary, VAIM Global, entered the skin booster market with JUVELOOK, which utilizes this technology. JUVELOOK is a collagen booster that induces the production of ECM (collagen, elastin) to provide direct remodeling effects on the skin such as elasticity and wrinkle improvement, and is divided into JUVELOOK and LENISNA depending on the purpose. After quickly proving its safety and effectiveness since its launch, VAIM Global currently has product export contracts with 72 countries.